Antonio Cubillo, director of HM Ciocc Madrid.
The Clara Campal Comprehensive Cancer Center, known as HM Ciocc, has presented its activity data during 2020. These have shown that, despite the impact and restrictions caused by the Covid-19 pandemic, it has maintained the care activity. Consolidating, according to reports from the center itself, as the first Cancer Center private of Spain by the number of new patients.
These data amount to 3,291 in the three HM Ciooc locations. Specifically, in Madrid have registered 2,975 cases, in Barcelona 202 and on Galicia 114. In relation to oncological consultations and visits, last year there were more than 50,000 and more than 18,000 cancer treatments under a pandemic context, this group of patients being declared at risk and with an intense healthcare activity that is unavoidable in the diagnosis and administration of treatments.
Care activity adapted to the pandemic
As the group points out, the pandemic “has not prevented HM Ciocc specialists from following carrying out their healthcare activity, attending to patients in person, through telephone follow-up and through video consultation; an essential service in HM Hospitales’ digital transformation strategy, and which has been revealed as maximum utility by avoiding unnecessary travel ”.
“We continue to be a private referral center for Spanish cancer patients due to the recognition of our professionals, advanced technology in early diagnosis and the quality and quantity of the multiple clinical trials in which we participate, which allow us to use new disruptive therapies, and which we develop from the earliest stages. This mixture of the human factor and the commitment to advance in individualized and precision oncology are the main reasons why year after year we are recipients of thousands of patients, who place their trust in us to accompany them in the process of approaching their pathology ”, he says Antonio Cubillo, director of HM Ciocc Madrid.
Breast tumor, the most diagnosed
Of the 3,291 new patients, 91 percent were diagnosed and treated for a solid tumor and the Remaining 9 percent of an oncohematologic tumor. In the case of patients with solid tumors, 28 percent were diagnosed with a breast tumor, 24 percent with a digestive tumor and 10 percent with a lung tumor.
The next most frequent oncological diagnoses were gynecological tumors with 6 percent and those of the genitourinary tract and melanoma with 5 percent. Among the tumor pathologies with the lowest incidence in the population, in 2020 HM Ciocc diagnosed a 1 percent of a tumor of unknown origin and 0.6 percent from a neuroendocrine tumor.
–
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Medical Writing is edited and prepared by journalists. We recommend that the reader be consulted with any health-related question with a healthcare professional.